H. Arak Et Al. , "The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma," Journal of Immunotherapy , vol.47, no.5, pp.182-189, 2024
Arak, H. Et Al. 2024. The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma. Journal of Immunotherapy , vol.47, no.5 , 182-189.
Arak, H., Erkiliç, S., YASLIKAYA, Ş., EYLEMER MOCAN, E., Aktaş, G., Özdemir, M., ... Semiz, H. S.(2024). The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma. Journal of Immunotherapy , vol.47, no.5, 182-189.
Arak, Haci Et Al. "The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma," Journal of Immunotherapy , vol.47, no.5, 182-189, 2024
Arak, Haci Et Al. "The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma." Journal of Immunotherapy , vol.47, no.5, pp.182-189, 2024
Arak, H. Et Al. (2024) . "The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma." Journal of Immunotherapy , vol.47, no.5, pp.182-189.
@article{article, author={Haci Arak Et Al. }, title={The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma}, journal={Journal of Immunotherapy}, year=2024, pages={182-189} }